Naveen Kumar serves as Rune Labs Chief Commercial Officer where he oversees the company’s commercial strategy and operations. Prior to joining Rune Labs, Naveen founded and led GuardantINFORM, the real-world data business of Guardant Health (NYSE: GH). Prior to Guardant, Naveen was Vice President and head of strategy for M2Gen, where he led the development of the ORIEN research network and the successful spin-out of the company from the Moffitt Cancer Center. Prior to M2Gen, Naveen worked in various roles in the finance and consulting industry working with life sciences companies. He holds a B.A. Economics with Honors from New York University and an M.Sc. Finance and Economics from the London School of Economics.